Although Sinclair Pharma Plc does not engage in early stage research, the company is committed to exploring the full potential of each of our products and technologies. Our experienced development personnel and consultants examine how products can be improved, whether through new presentations, delivery systems, or combinations of technologies.

Sinclair is currently developing products in the following therapeutic areas: dermatology, oral health and eye care. Click here for a list of pipeline products.

Where Sinclair products show potential outside these therapeutic areas, the clinical and commercial potential of such a development is carefully assessed.